GIULIANI, FRANCESCA LICIA
 Distribuzione geografica
Continente #
NA - Nord America 397
AS - Asia 121
EU - Europa 54
SA - Sud America 19
AF - Africa 2
Totale 593
Nazione #
US - Stati Uniti d'America 395
SG - Singapore 48
CN - Cina 25
BR - Brasile 15
RU - Federazione Russa 14
HK - Hong Kong 13
SE - Svezia 13
FR - Francia 10
VN - Vietnam 8
GB - Regno Unito 5
IN - India 5
DE - Germania 4
BD - Bangladesh 3
IQ - Iraq 3
AR - Argentina 2
AT - Austria 2
ID - Indonesia 2
KG - Kirghizistan 2
MX - Messico 2
PK - Pakistan 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BE - Belgio 1
CO - Colombia 1
ES - Italia 1
ET - Etiopia 1
FI - Finlandia 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KR - Corea 1
KZ - Kazakistan 1
MY - Malesia 1
PY - Paraguay 1
RO - Romania 1
TR - Turchia 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 593
Città #
Ashburn 62
Fairfield 57
Chandler 41
Singapore 28
San Jose 25
Houston 22
Woodbridge 21
Cambridge 19
Seattle 15
Hong Kong 13
Wilmington 13
Beijing 12
Nyköping 11
Ann Arbor 7
Los Angeles 6
Des Moines 5
Lauterbourg 5
Lawrence 5
Roxbury 5
Columbus 4
Council Bluffs 4
Inglewood 4
The Dalles 4
Paris 3
São Paulo 3
Atlanta 2
Chicago 2
Dallas 2
Frankfurt am Main 2
Hanoi 2
London 2
New York 2
Pune 2
San Diego 2
Tashkent 2
Vienna 2
Addis Ababa 1
Almaty 1
Amman 1
Ankara 1
As Samawah 1
Asunción 1
Baku 1
Belo Horizonte 1
Bhopal 1
Bishkek 1
Boardman 1
Bogor 1
Bradford 1
Brasília 1
Brussels 1
Buenos Aires 1
Campinas 1
Carlos Casares 1
Chongqing 1
Dearborn 1
Denver 1
Faridabad 1
Ghaziabad 1
Grafing 1
Greenville 1
Hefei 1
Helsinki 1
Ho Chi Minh City 1
Itauçu 1
Jerusalem 1
Johannesburg 1
Juazeiro do Norte 1
Karbala 1
Kharian 1
Laguna 1
Las Vegas 1
Medellín 1
Mexico City 1
Moscow 1
Munich 1
Muriaé 1
Muskegon 1
Najaf 1
Nanjing 1
Ninh Bình 1
Orangeburg 1
Palhoça 1
Petaling Jaya 1
Phoenix 1
Portsmouth 1
Queens 1
Quận Mười 1
Rio Brilhante 1
San Francisco 1
Santa Clara 1
Sarandi 1
Seoul 1
Surabaya 1
São Gotardo 1
São José 1
Tlalnepantla 1
Tây Ninh 1
Xiamen 1
Zagreb 1
Totale 480
Nome #
HER-2 inhibition in gastric and colorectal cancers: Tangible achievements, novel acquisitions and future perspectives 131
Current status of targeted therapies in advanced gastric cancer 127
Cetuximab plus FOLFOX-4 in untreated patients with advanced colorectal cancer: A gruppo oncologico dell'Italia meridionale multicenter phase II study 119
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option? 116
Human epidermal growth factor receptor 2 (HER2) in gastric cancer: A new therapeutic target 105
Totale 598
Categoria #
all - tutte 2.745
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.745


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 2 8 0
2021/202243 0 9 1 2 4 0 2 2 1 0 4 18
2022/202392 9 11 8 7 5 11 3 11 18 2 6 1
2023/202419 0 4 1 6 1 5 1 0 0 0 0 1
2024/202589 0 3 7 2 1 18 5 11 0 7 11 24
2025/2026176 34 12 8 8 32 12 23 5 27 15 0 0
Totale 598